SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-17-002759
Filing Date
2017-01-18
Accepted
2017-01-18 14:25:14
Documents
1
Group Members
MONTREUX EQUITY MANAGEMENT IV, LLCMONTREUX EQUITY MANAGEMENT V, LLCMONTREUX EQUITY PARTNERS V, L.P.MONTREUX IV ASSOCIATES, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-2652_1sc13ga.htm SC 13G/A 156998
  Complete submission text file 0001104659-17-002759.txt   158923
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Subject) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87592 | Film No.: 17533177
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111
Business Address ONE FERRY BUILDING, SUITE 255 SAN FRANCISCO CA 94111 650-234-1200
MONTREUX EQUITY PARTNERS IV LP (Filed by) CIK: 0001423641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CA
Type: SC 13G/A